BUB1 and glioma: Although the mechanisms of action are not fully understood and still controversial, different studies correlated BUB1 expression (and limitedly BUB1 mutations) with poor prognosis in several cancers, including breast cancer, glioma, prostate cancer, and salivary gland tumours24–28.